Fritschi J, Christe M, Lämmle B, Marbet G A, Berger W, Duckert F
Thromb Haemost. 1984 Dec 29;52(3):236-9.
We have studied 155 subjects, 48 normals, 36 diabetics without complications, 44 with complications and 27 patients with macroangiopathy. beta-Thromboglobulin (beta-TG) and platelet factor 4 (PF4) are elevated in the patients groups. There is no correlation between the plasma levels of beta-TG and the stages of either retinopathy or macroangiopathy or nephropathy. The difference is more marked between normals and diabetics with neuropathy (p = 0.026). The aggregation response to ADP and platelet activating factor (PAF) is enhanced at lower stimulator concentration. Using the beta-TG, PF4 and aggregation values the discriminant analysis allows a distinction of several subgroups especially with nephropathy and neuropathy (Table 6).
我们研究了155名受试者,其中48名正常人,36名无并发症的糖尿病患者,44名有并发症的患者以及27名患有大血管病变的患者。β-血小板球蛋白(β-TG)和血小板因子4(PF4)在患者组中升高。β-TG的血浆水平与视网膜病变、大血管病变或肾病的阶段之间没有相关性。正常人与患有神经病变的糖尿病患者之间的差异更为明显(p = 0.026)。在较低的刺激物浓度下,对ADP和血小板活化因子(PAF)的聚集反应增强。使用β-TG、PF4和聚集值进行判别分析可以区分几个亚组,尤其是肾病和神经病变亚组(表6)。